Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 43,112 | 30,578 | 19,821 | 15,029 | 12,977 |
| Operating Income | -43,112 | -30,578 | -19,821 | -15,029 | -12,977 |
| Other Income | 7,090 | 5,898 | 5,915 | 7,186 | 1,386 |
| Pre-tax Income | -36,022 | -24,680 | -13,905 | -7,843 | -11,590 |
| Income Tax | 92 | 79 | 70 | 44 | 29 |
| Net Income Continuous | -36,114 | -24,759 | -13,976 | -7,887 | -11,619 |
| Minority Interests | -724 | -492 | -302 | -450 | -2,193 |
| Net Income | $-35,390 | $-24,267 | $-13,674 | $-7,437 | $-9,426 |
| EPS Basic Total Ops | -0.56 | -0.39 | -0.22 | -0.09 | -0.18 |
| EPS Basic Continuous Ops | -0.57 | -0.39 | -0.22 | -0.08 | -0.22 |
| EPS Diluted Total Ops | -0.56 | -0.39 | -0.22 | -0.09 | -0.18 |
| EPS Diluted Continuous Ops | -0.57 | -0.39 | -0.22 | -0.08 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.56 | -0.39 | -0.22 | -0.12 | -0.18 |
| EBITDA(a) | $-43,080 | $-30,550 | $-19,798 | $-15,026 | $-12,974 |